Organovo
ONVO
#11111
Rank
A$5.42 M
Marketcap
A$3.01
Share price
1.49%
Change (1 day)
264.66%
Change (1 year)

P/E ratio for Organovo (ONVO)

P/E ratio on November 15, 2026 (TTM): -0.1771

According to Organovo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.177083. At the end of 2024 the company had a P/E ratio of -2.92.

P/E ratio history for Organovo from 2021 to 2024

PE ratio at the end of each year

Year P/E ratio Change
2024-2.92179.27%
2023-1.05-57.59%
2022-2.4753.09%
2021-1.61

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
General Electric
GE
37.8-21,442.31%๐Ÿ‡บ๐Ÿ‡ธ USA
3M
MMM
27.5-15,606.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Intuitive Surgical
ISRG
53.4-30,281.10%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
20.8-11,843.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Stratasys
SSYS
-4.29 2,325.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
3D Systems
DDD
-2.90 1,539.46%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.